Mutual Fund Details
NAV
₹36.8390
as on 02 Jul 2024, 09:00 PM
₹0.2610(0.71%)
Last Change
Scheme Ratings
1
Pharma
5Y Returns
3
rated by Value Research
Pharma
Rankings based on 5Y Returns | as on 03 Jul 2024
×
1
DSP Healthcare Fund Direct - Growth
29.62%
2
Mirae Asset Healthcare Fund Direct - Growth
28.50%
3
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
28.46%
4
SBI Healthcare Opportunities Fund Direct Plan-Growth
27.99%
5
Nippon India Pharma Fund Direct-Growth
26.68%
Schemes Managed By
Investment Performance
would have given a return of
₹1,10,871
₹1,21,647
₹1,53,728
₹1,60,156
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
₹60,156
Profit (absolute return)
60.16%
in the last
1m
3m
1y
3y
5y
max
+1% Higher Returns
With Direct Plans on Paytm MoneyInvestment Returns
In the last 3 months
2.25%
In the last 6 months
14.37%
In the last 1 year
41.77%
In the last 3 years
60.16%
In the last 5 years
266.40%
In the last 10 years
NA
Absolute Returns
CAGR
Scheme Riskometer
low
low to moderate
moderate
moderately high
high
very high
Investors understand that their principal will be at very high risk
Scheme Information
DSP Healthcare Fund Direct - Growth
as of 31 May 2024, 05:30 AM
₹2,363.39 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 0.50% if redeemed within 1 month.
0.63%
Expense Ratio
Plan
Growth
Benchmark
BSE Healthcare Total Return Index
Exit Load
Exit load of 0.50% if redeemed within 1 month.
Scheme Document
Companies Holding in this Mutual Fund
as on 31 May 2024
Sun Pharmaceutical Industries Ltd.
12.59%
₹297.55 Cr
Cipla Ltd.
8.49%
₹200.65 Cr
Ipca Laboratories Ltd.
7.82%
₹184.82 Cr
Suven Pharmaceuticals Ltd.
7.56%
₹178.67 Cr
Lupin Ltd.
7.32%
₹173.00 Cr
Others
56.22%
₹1,328.70 Cr
View All
View All
This fund's returns:
16.98%Return Duration
3 Years
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
EquityPharma
Min. Investment
₹100
Category Returns
10.31%
17.37%
3Y Returns
17.37
SBI Healthcare Opportunities Fund Direct Plan-Growth
EquityPharma
Min. Investment
₹500
Category Returns
10.31%
17.37%
3Y Returns
16.95
Tata India Pharma & HealthCare Fund Direct-Growth
EquityPharma
Min. Investment
₹100
Category Returns
10.31%
17.37%
3Y Returns
16.65
About DSP Healthcare Fund Direct - Growth
DSP Healthcare Fund Direct - Growth is a Equity mutual fund scheme from DSP Mutual Fund. This scheme was launched on Invalid date and is currently managed by its fund manager Chirag Dagli. It has an AUM of ₹2,363.39 Crores and the latest NAV decalared is ₹36.839 as on 03 Jul 2024 at 7:56 pm.
DSP Healthcare Fund Direct - Growth scheme return performance in last 1 year is 41.77%, in last 3 years is 60.16% and 263.82% since scheme launch.
Scheme Details
| AUM: | ₹2,363.39 Cr |
| Category: | Equity: Sectoral-Pharma |
| Launch Date: | Invalid date |
| Fund Type: | Open-End |
AMC Information
DSP Mutual Fund
View AMC Details
₹1,58,858.93 Cr
AUM
154
Schemes
Address
NATRAJ, Office No. 302-3rd Floor-Plot No. 194, MV Road JunctionWestern Express Highway, Andheri East400069
Phone Number
Phone : 1800-208-4499 / 1800-200-4499
Fax : 022-56578181
Email / Website
Start investing in minutes
Download app to Explore
Scan this QR code to download the app now!
Or download from
